They got slammed. The credibility of this company has been damaged and will continue to be so for some time until they can deliver.

When all is said and done, we expect the company will likely be able to exceed its conservative forecast.

The squeeze is coming, ... With this number of cases and these types of awards, the stability of the company is at risk.

The legal victory represents a significant reduction in the risk profile of the company. The company's fending off of this major threat is likely to lift sentiment for the entire large-cap pharmaceutical group through the remainder of 2005.

We are hopeful that the company will lay out more conservative guidance for 2002 as a means to rebuild credibility with investors.

[With Gerstner, the company hopes to restore its credibility and add a financial juggernaut all in one deft move.] It's clear they are trying to button up some of their previous problems with PR and to deflect criticism about all of their purchasing of former U.S. officials, ... It's a move that is clearly designed to make them look like a regular company.